- Q4 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 07, 2024$1.13Earnings
- Q3 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 09, 2023$1.07 (-2.73%)Earnings
- Q2 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 10, 2023$1.41 (-2.08%)Earnings
- Q1 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 11, 2023$1.41 (-1.40%)Earnings
- Q4 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 09, 2023$1.46Earnings
- Q3 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 10, 2022$1.33 (+6.40%)Earnings
- Q2 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 11, 2022$1.55 (-0.64%)Earnings
- Q1 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 12, 2022$1.18 (-0.84%)Earnings
- Lineage Cell Therapeutics Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 27, 2022
- Lineage Cell Therapeutics Inc at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 20, 2022
- Q4 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 10, 2022$1.4 (-1.41%)Earnings
- Lineage Cell Therapeutics Inc To Discuss Worldwide OpRegen Collaboration Call TranscriptDec 20, 2021
- Q3 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 10, 2021$2.36 (-4.45%)Earnings
- Lineage Cell Therapeutics Inc at B Riley Fall Growth Biotech Best Ideas (Virtual) TranscriptOct 18, 2021
- Q2 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 12, 2021$2.61 (-1.51%)Earnings
- Lineage Cell Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 22, 2021
- Lineage Cell Therapeutics Inc Webinar Featuring External Therapeutic Area Experts TranscriptJun 10, 2021
- Q1 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 13, 2021$2.17 (-4.41%)Earnings
- Q4 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 11, 2021$2.34 (+4.00%)Earnings
- Lineage Cell Therapeutics Inc Corporate Analyst Meeting TranscriptFeb 22, 2021
- Lineage Cell Therapeutics, Inc. - Special Call TranscriptNov 17, 2020
- Q3 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 04, 2020$1.21 (-0.82%)Earnings
- Q2 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 06, 2020$0.92 (+5.02%)Earnings
- Lineage Cell Therapeutics, Inc. - Special Call TranscriptJun 08, 2020
- Lineage Cell Therapeutics, Inc. - Special Call TranscriptMay 11, 2020
- Q1 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 07, 2020$0.957 (+0.21%)Earnings
- Q4 2019 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 12, 2020$0.6801 (-14.10%)Earnings
- Lineage Cell Therapeutics Inc at Solebury Trout KOL Day TranscriptNov 15, 2019
- Q3 2019 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 12, 2019$0.72 (-1.37%)Earnings
- Q2 2019 BioTime Inc Earnings Call TranscriptAug 08, 2019$0.99 (-1.98%)Earnings
- Q1 2019 BioTime Inc Earnings Call TranscriptMay 09, 2019$1.18 (-1.67%)Earnings
- Q4 2018 BioTime Inc Earnings Call TranscriptMar 14, 2019$1.55 (-1.27%)Earnings
Lineage Cell Therapeutics, Inc. - Special Call Transcript
Hello, and welcome, everybody, to today's call. My name is Brian Culley, and I'm the CEO at Lineage Cell Therapeutics. I'd like to thank you for joining today and learning more about the exciting work we're doing in cell therapy, and more specifically, our allogeneic cell transplant technology, which we believe can lead to clinical outcomes which are out of the reach of traditional therapeutic approaches.
The reason for our call today is that thanks to an unexpected surge of 4 patients being treated in just 8 days, we recently completed enrollment of all 24 patients in a Phase I/IIa clinical trial and felt this is a great time to provide a more fulsome update.
Before I introduce our therapeutic expert today, we have a lot of new followers, and I want to ensure that everyone is starting from the same baseline. So I'm going to present just 5 slides to remind you about our, work and then I will introduce Dr. Riemann, who will be able to do a deep dive into the data which we have generated to date.
So
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)